A randomized trial to assess the cardiovascular mortality of sevelamer versus calcium carbonate (TUMS) in incident hemodialysis patients.






**************************************

Estimated Time to View: 20 minutes
Title: Sevelamer versus TUMS in Incident Hemodialysis Patients
Author: Ananda Gurram, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2013, Volume 4, Number 19
Disclaimers: None
Resource Type: Twitter Transcript
Recommend to a Colleague/Friend: Roll Over
Review this teaching resource: Click here

Pin this resource

**************************************





LEARNING OPTIONS:


Read transcript





Transparent Peer Review



GD Star Rating
loading...



To learn more about our 6-point transparent peer review system, click here



Share

Comments

  • Nephrology On-Demand Plus


    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


    Available_on_the_App_Store_(black)

  • Kidney Konnection


    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
More in End-Stage Renal Disease, Hemodialysis, Renal Replacement (2 of 61 articles)